Is nodal involvement still relevant to assign adjuvant systemic treatment in early breast cancer?

The Breast ◽  
2003 ◽  
Vol 12 ◽  
pp. S25
Author(s):  
M. Gennaro ◽  
A.R. Conti ◽  
C. Ferraris ◽  
P. Lepera ◽  
M. Greco
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Systemic Treatment ◽  
Nodal Involvement ◽  
Adjuvant Systemic Treatment

scholarly journals Adjuvant systemic treatment of early breast cancer: the NORA study

2006 ◽  
Vol 17 (9) ◽  
pp. 1386-1392 ◽  
Author(s):  
M.E. Cazzaniga ◽  
G. Mustacchi ◽  
P. Pronzato ◽  
A. De Matteis ◽  
F. Di Costanzo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Systemic Treatment ◽  
Adjuvant Systemic Treatment

Patients’ preferences for surgical and adjuvant systemic treatment in early breast cancer: A systematic review

2014 ◽  
Vol 40 (8) ◽  
pp. 1005-1018 ◽  
Author(s):  
Victoria C. Hamelinck ◽  
Esther Bastiaannet ◽  
Arwen H. Pieterse ◽  
Ilse Jannink ◽  
Cornelis J.H. van de Velde ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Early Breast Cancer ◽  
Systemic Treatment ◽  
Adjuvant Systemic Treatment

scholarly journals Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer

2020 ◽  
Vol 14 ◽  
pp. 117955492093181
Author(s):  
Francesca Parisi ◽  
Maria Grazia Razeti ◽  
Eva Blondeaux ◽  
Luca Arecco ◽  
Marta Perachino ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Systemic Treatment ◽  
Premenopausal Women ◽  
Specific Patient ◽  
Adjuvant Systemic Treatment ◽  
Current State ◽  
Age Related ◽  
Advanced Stages ◽  
Premenopausal Patients

Breast cancer is the most frequent malignancy diagnosed in premenopausal women. In this age group, breast tumors tend to be diagnosed at more advanced stages and to harbor more aggressive biological features. In addition, specific age-related issues including genetic counseling, fertility preservation, impact on social and couple relationships, working life, and management of long-term side effects should be considered highly relevant when managing early breast cancer in premenopausal women. Therefore, the care of these patients is particularly complex and a multidisciplinary approach is mandatory. The present review summarizes the current state of art in the adjuvant systemic treatment of premenopausal women with early breast cancer focusing on the optimal chemotherapy, endocrine therapy, and targeted therapy approaches in this specific patient population.

scholarly journals Adjuvant systemic treatment for individual patients with triple negative breast cancer

The Breast ◽  
2011 ◽  
Vol 20 ◽  
pp. S135-S141 ◽  
Author(s):  
Catherine Oakman ◽  
Erica Moretti ◽  
Francesca Galardi ◽  
Chiara Biagioni ◽  
Libero Santarpia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Systemic Treatment ◽  
Adjuvant Systemic Treatment
Sign in / Sign up

Export Citation Format

Share Document